Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ANVS Annovis Bio Inc

Price (delayed)

$1.69

Market cap

$32.93M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.11

Enterprise value

$10.7M

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS). ...

Highlights
ANVS's equity has surged by 158% since the previous quarter
The EPS has surged by 59% year-on-year but it has declined by 4.5% since the previous quarter
The net income is up by 39% year-on-year but it is down by 18% since the previous quarter

Key stats

What are the main financial stats of ANVS
Market
Shares outstanding
19.49M
Market cap
$32.93M
Enterprise value
$10.7M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$25.17M
Net income
-$29.06M
EBIT
-$29.06M
EBITDA
-$29.06M
Free cash flow
-$22.96M
Per share
EPS
-$2.11
EPS diluted
-$2.15
Free cash flow per share
-$1.32
Book value per share
$1.23
Revenue per share
$0
TBVPS
$1.53
Balance sheet
Total assets
$26.74M
Total liabilities
$2.68M
Debt
$0
Equity
$24.05M
Working capital
$24.23M
Liquidity
Debt to equity
0
Current ratio
10.68
Quick ratio
8.88
Net debt/EBITDA
0.77
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-193.5%
Return on equity
-300.6%
Return on invested capital
N/A
Return on capital employed
-119.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANVS stock price

How has the Annovis Bio stock price performed over time
Intraday
-0.59%
1 week
6.96%
1 month
36.29%
1 year
-79.78%
YTD
-66.4%
QTD
12.67%

Financial performance

How have Annovis Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.17M
Net income
-$29.06M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 41% YoY and by 6% QoQ
The net income is up by 39% year-on-year but it is down by 18% since the previous quarter

Price vs fundamentals

How does ANVS's price correlate with its fundamentals

Growth

What is Annovis Bio's growth rate over time

Valuation

What is Annovis Bio stock price valuation
P/E
N/A
P/B
1.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 59% year-on-year but it has declined by 4.5% since the previous quarter
ANVS's equity has surged by 158% since the previous quarter
The price to book (P/B) is 83% less than the 5-year quarterly average of 8.3

Efficiency

How efficient is Annovis Bio business performance
The company's return on equity has surged by 74% YoY and by 66% QoQ
The return on assets is up by 48% year-on-year and by 19% since the previous quarter

Dividends

What is ANVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANVS.

Financial health

How did Annovis Bio financials performed over time
ANVS's current ratio has soared by 197% from the previous quarter
Annovis Bio's total assets has surged by 92% QoQ
The company's debt is 100% lower than its equity
ANVS's equity has surged by 158% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.